PubRank

S S Wasserman

Author PubWeight™ 101.63‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich. JAMA 1992 6.88
2 Determinants of HIV-1 shedding in the genital tract of women. Lancet 2001 5.10
3 Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection. J Clin Invest 1993 4.53
4 Vibrio cholerae produces a second enterotoxin, which affects intestinal tight junctions. Proc Natl Acad Sci U S A 1991 3.43
5 Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lancet 1998 2.98
6 Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans. Infect Immun 1997 2.44
7 Phase II safety and immunogenicity study of live chikungunya virus vaccine TSI-GSD-218. Am J Trop Med Hyg 2000 2.39
8 Reduction of transmission of shigellosis by control of houseflies (Musca domestica) Lancet 1991 2.30
9 Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi. J Infect Dis 1994 2.03
10 A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity. Vaccine 1995 1.74
11 Role of Vibrio cholerae neuraminidase in the function of cholera toxin. Infect Immun 1992 1.72
12 Seroprevalence of Helicobacter pylori in Seventh-Day Adventists and other groups in Maryland. Lack of association with diet. Arch Intern Med 1990 1.68
13 Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area. Vaccine 2000 1.67
14 Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA. Infect Immun 1999 1.66
15 Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei. Infect Immun 1990 1.64
16 Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers. Infect Immun 2000 1.63
17 Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission. J Infect Dis 1993 1.59
18 An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis. J Infect Dis 1992 1.55
19 Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect Immun 2001 1.50
20 Safety, immunogenicity, and excretion pattern of single-dose live oral cholera vaccine CVD 103-HgR in Peruvian adults of high and low socioeconomic levels. Infect Immun 1993 1.40
21 Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination. Infect Immun 1999 1.38
22 Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2. Vaccine 1995 1.38
23 Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections. Pediatr Infect Dis J 1996 1.38
24 Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial. Infect Immun 1992 1.35
25 Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR. J Infect Dis 1999 1.35
26 Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun 1996 1.32
27 Detection and quantitation of human immunodeficiency virus type 1 in the female genital tract. The Division of AIDS Treatment Research Initiative 009 Study Group. J Clin Microbiol 2000 1.31
28 Goldfish, Carassius auratus, a novel animal model for the study of Mycobacterium marinum pathogenesis. Infect Immun 1998 1.28
29 Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults. Infect Immun 2001 1.23
30 Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera. Infect Immun 1996 1.21
31 Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge. J Clin Invest 1992 1.21
32 A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans. J Infect Dis 1994 1.19
33 Release of tumor necrosis factor alpha in response to Vibrio vulnificus capsular polysaccharide in in vivo and in vitro models. Infect Immun 1997 1.15
34 A voluntary serosurvey and behavioral risk assessment for human immunodeficiency virus infection among college students. Sex Transm Dis 1992 1.15
35 Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C. Clin Immunol 2000 1.14
36 Acute diarrhea in Baltimore children attending an outpatient clinic. Pediatr Infect Dis J 1988 1.05
37 Effect of priming with carrier on response to conjugate vaccine. Lancet 1989 1.03
38 Assessment of the prevalence and risk factors for human immunodeficiency virus type 1 (HIV-1) infection among college students using three survey methods. Am J Epidemiol 1991 1.02
39 Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915. Infect Immun 2001 1.01
40 Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection. Infect Immun 1993 1.00
41 Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers. Pediatr Infect Dis J 1999 1.00
42 Phase 1 trial of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered simultaneously. Vaccine 1994 1.00
43 Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru. Infect Immun 1997 0.99
44 A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali. Bull World Health Organ 1998 0.99
45 Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O. Trans R Soc Trop Med Hyg 1995 0.97
46 Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 1998 0.96
47 Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun 1991 0.96
48 Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization. Pediatrics 1999 0.95
49 Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines. Am J Trop Med Hyg 2003 0.95
50 The frequency of astrovirus as a cause of diarrhea in Baltimore children. Pediatr Infect Dis J 1992 0.95
51 Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings. Pediatrics 1989 0.95
52 Safety and immunogenicity of an HLA-based HIV envelope polyvalent synthetic peptide immunogen. DATRI 010 Study Group. Division of AIDS Treatment Research Initiative. AIDS 1998 0.94
53 Increases in [Ca2+]i mediated by the 92.5-kDa putative cell membrane receptor for HCMV gp86. Am J Physiol 1995 0.92
54 Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections. Pharmacotherapy 2000 0.91
55 Rotavirus-specific breast milk antibody in two populations and possible correlates of interference with rhesus rotavirus vaccine seroconversion. J Infect Dis 1992 0.89
56 Comparison of immunogenicity and efficacy of rhesus rotavirus reassortant vaccines in breastfed and nonbreastfed children. US Rotavirus Vaccine Efficacy Group. Pediatrics 1995 0.87
57 Resource concentration and herbivory in oak forests. Science 1980 0.86
58 Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions. Clin Exp Immunol 1989 0.86
59 Vibrio cholerae ACE stimulates Ca(2+)-dependent Cl(-)/HCO(3)(-) secretion in T84 cells in vitro. Am J Physiol Cell Physiol 2000 0.86
60 Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama. Infect Immun 1999 0.85
61 [Tolerance and immunogenicity of an oral dose of CVD 103-HgR, a live attenuated Vibrio cholerae 01 strain: a double-blind study of Chilean adults]. Rev Med Chil 1993 0.84
62 A serosurvey of pathogens associated with shellfish: prevalence of antibodies to Vibrio species and Norwalk virus in the Chesapeake Bay region. Am J Epidemiol 1992 0.84
63 Quantitative relationship between oral temperature and severity of illness following inoculation with candidate attenuated dengue virus vaccines. Clin Infect Dis 1994 0.83
64 Effects of anatomic site, oral stimulation, and body position on estimates of body temperature. Arch Intern Med 1996 0.83
65 Repeated measurement of spontaneous and clastogen-induced sister-chromatid exchange. Mutat Res 1990 0.82
66 Multiple blood-borne and sexually transmitted infections in sexually transmitted disease clinic and hospital emergency room patient populations. Sex Transm Dis 1993 0.80
67 Effects of IFN-beta on human cerebral blood flow distribution. J Interferon Cytokine Res 1998 0.79
68 Spontaneous and clastogen induced chromosomal breakage in scleroderma. J Rheumatol 1991 0.78
69 Plasmids in Salmonella typhi in Lima, Peru, 1987-1988: epidemiology and lack of association with severity of illness or clinical complications. Am J Trop Med Hyg 1992 0.78
70 Antibodies that react with the capsular polysaccharide of Vibrio vulnificus are detectable in infected patients, and in persons without known exposure to the organism. Diagn Microbiol Infect Dis 1996 0.77
71 Association between anti-CD4 antibodies and a decline in CD4+ lymphocytes in human immunodeficiency virus type 1 seroconverters. J Infect Dis 1995 0.77
72 Relationship between humoral immune responses and oral temperature during human shigellosis. J Infect Dis 1993 0.76
73 Diurnal biting activity and transmission of Onchocerca volvulus (Filariata: Onchocercidae) by Simulium yahense (Diptera: Simuliidae) in Liberia. J Med Entomol 1994 0.76
74 Physicians' perceptions regarding body temperature in health and disease. South Med J 1995 0.75
75 No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe. J Infect Dis 1996 0.75
76 Partial paternal inheritance of realized fecundity in a bruchid beetle, Callosobruchus maculatus. Behav Genet 1988 0.75
77 Effects of theophylline on chromosomal breakage and sister-chromatid exchange. Mutat Res 1989 0.75
78 Serologic response to Helicobacter pylori among children and teenagers in northern Chile. Am J Trop Med Hyg 1993 0.75